4.3 Review

Notch signalling beyond liver development: Emerging concepts in liver repair and oncogenesis

出版社

ELSEVIER MASSON, CORP OFF
DOI: 10.1016/j.clinre.2013.05.008

关键词

-

资金

  1. NIH [DK079005]
  2. PRIN [2009ARYX4T 005]
  3. CARIPLO [2011-0470]
  4. Fondazione Telethon [GGP09-189]

向作者/读者索取更多资源

Notch signalling is an evolutionarily conserved intercellular pathway involved in many aspects of development and tissue renewal in several organs. The importance of Notch signalling in liver development and morphogenesis is well established. However, the post-natal role of Notch in liver repair/regeneration is only now beginning to be unveiled. Despite the simplicity of the pathway activation, a fine spatial-temporal regulation of Notch signalling is required to avoid pathologic effects. This review highlights recent advances in the field indicating that Notch signalling is involved in the reparative morphogenesis of the biliary tree and in liver carcinogenesis. Defective Notch signalling leads to impaired ability of the liver to repair liver damage, while excessive activation may be involved in liver cancer. Even though much remains to be understood about these mechanisms, including the cross-talk between Notch signalling and other liver morphogens, current evidence suggests that the modulation of the Notch pathway may represent a therapeutic target in chronic liver disease. (C) 2013 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumors-stroma crosstalk in experimental models

Paula Olaizola, Pui Yuen Lee-Law, Maite G. Fernandez-Barrena, Laura Alvarez, Massimiliano Cadamuro, Mikel Azkargorta, Colm J. O'Rourke, Francisco J. Caballero-Camino, Irene Olaizola, Rocio I. R. Macias, Jose J. G. Marin, Marina Serrano-Macia, Maria L. Martinez-Chantar, Matias A. Avila, Patricia Aspichueta, Diego F. Calvisi, Matthias Evert, Luca Fabris, Rui E. Castro, Felix Elortza, Jesper B. Andersen, Luis Bujanda, Pedro M. Rodrigues, Maria J. Perugorria, Jesus M. Banales

Summary: The study found that NEDDylation plays a crucial role in the development and progression of cholangiocarcinoma, inhibition of NEDDylation can suppress CCA cell proliferation and prevent tumor formation, showing potential therapeutic effects in inhibiting CCA cell growth and stroma interaction.

JOURNAL OF HEPATOLOGY (2022)

Review Health Care Sciences & Services

Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma

Massimiliano Cadamuro, Adriana Romanzi, Maria Guido, Samantha Sarcognato, Umberto Cillo, Enrico Gringeri, Giacomo Zanus, Mario Strazzabosco, Paolo Simioni, Erica Villa, Luca Fabris

Summary: The prognosis of cholangiocarcinoma is still poor despite advances in immunotherapy and molecular profiling. Surgical procedures like liver resection and transplantation offer the best chances for cure, but lymph node metastases can compromise treatment outcomes. Tumor-associated lymphangiogenesis plays a crucial role in the invasiveness and progression of cholangiocarcinoma, which has been largely overlooked until recently. Understanding the intercellular signaling and molecular mechanisms of tumor-associated lymphangiogenesis may help identify new therapeutic targets to improve treatment success rates.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Gastroenterology & Hepatology

Rational development of combination therapies for biliary tract cancers

James J. Harding, Danny N. Khalil, Luca Fabris, Ghassan K. Abou-Alfa

Summary: Biliary tract cancers are rare gastrointestinal malignancies associated with high morbidity and mortality rates. Various treatments, including chemotherapy, precision medicine, and immunotherapy, are used in both standard-of-care and investigational settings. Recent research has shown that the combination of durvalumab with gemcitabine and cisplatin improves survival outcomes. Precision medicine is utilized in patients with specific genetic alterations, while fluoropyridine doublets are used in patients without targetable genetic alterations. Next-generation sequencing is crucial for patient care and understanding resistance mechanisms. Ongoing clinical trials seek to improve treatment standards and develop effective combination drug therapies for the future.

JOURNAL OF HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma

Massimiliano Cadamuro, Ahmad Al-Taee, Tamas A. Gonda

Summary: Cholangiocarcinoma is a deadly malignancy that is often diagnosed late due to its intrinsic characteristics and the growth pattern of cancer cells. However, early and accurate diagnosis, as well as identification of targetable changes, can potentially improve survival. Primary sclerosing cholangitis, a precursor to a minority of cholangiocarcinomas, poses particular diagnostic challenges. This article presents a comprehensive diagnostic and theranostic approach to extrahepatic cholangiocarcinoma, incorporating advanced imaging, endoscopic methods, multiple tissue sampling approaches, and molecular markers. An algorithm for sequential tool usage is also provided.

JOURNAL OF HEPATOLOGY (2023)

Review Cell Biology

The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored

Alessandro Gambella, Silvia Kalantari, Massimiliano Cadamuro, Marco Quaglia, Maurizio Delvecchio, Luca Fabris, Michele Pinon

Summary: The hepatocyte nuclear factor 1 beta (HNF1B) gene plays a crucial role in the development of specialized epithelia in various organs during embryogenesis. Pathogenic variants of HNF1B have been associated with a complex syndrome that mainly affects children, leading to diabetes and renal complications. However, recent studies have highlighted the importance of liver involvement, including a potential link to tumor development, expanding the understanding of HNF1B-associated disease. This review aims to provide a comprehensive analysis of the genetic, phenotypic, and clinical features of HNF1B deficiency in both pediatric and adult populations.
Article Biochemistry & Molecular Biology

Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma

Massimiliano Cadamuro, Samantha Sarcognato, Riccardo Camerotto, Noemi Girardi, Alberto Lasagni, Giacomo Zanus, Umberto Cillo, Enrico Gringeri, Giovanni Morana, Mario Strazzabosco, Elena Campello, Paolo Simioni, Maria Guido, Luca Fabris

Summary: Metabolic syndrome (MetS) is associated with the development of intrahepatic cholangiocarcinoma (iCCA), a liver tumor. MetS iCCAs have increased deposition of osteopontin (OPN), tenascin C (TnC), and periostin (POSTN) in the extracellular matrix (ECM), which stimulates cell motility and cancer-stem-cell-like phenotype. OPN overexpression may serve as a predictive biomarker and therapeutic target for MetS iCCA.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Gastroenterology & Hepatology

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

Diego Calvisi, Luke Boulter, Javier Vaquero, Anna Saborowski, Luca M. Fabris, Pedro Rodrigues, Cedric E. Coulouarn, Rui Castro, Oreste Segatto, Chiara Raggi, Luc J. W. van der Laan, Guido Carpino, Benjamin Goeppert, Stephanie J. Roessler, Timothy Kendall, Matthias Evert, Ester W. Gonzalez-Sanchez, Juan Valle, Arndt Vogel, John J. Bridgewater, Mitesh J. Borad, Gregory R. Gores, Lewis Roberts, Jose J. G. B. Marin, Jesper Andersen, Domenico Alvaro, Alejandro M. Forner, Jesus Banales, Vincenzo Cardinale, Rocio I. R. Macias, Silve Vicent, Xin Chen, Chiara Braconi, Monique M. A. Verstegen, Laura Fouassier, Lewis Roberts, Alexander Scheiter, Florin M. Selaru, Katja Evert, Kirsten Utpatel, Laura Broutier, Massimiliano Cadamuro, Meritxell Huch, Robert Goldin, Sergio A. Gradilone, Yoshimasa Saito

Summary: In this Consensus Statement, experts provide recommendations on the criteria for preclinical models of cholangiocarcinoma (CCA) to increase disease understanding and develop novel therapeutic approaches.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models

Paolo Rainone, Silvia Valtorta, Chiara Villa, Sergio Todde, Massimiliano Cadamuro, Gloria Bertoli, Donatella Conconi, Marialuisa Lavitrano, Rosa Maria Moresco

Summary: Breast cancer is the most common cancer in women and the second leading cause of death. Breast cancer cells show a metabolic shift towards increased glycolysis, making it an interesting target for metabolic drugs such as metformin. Recent studies have found that the antihypertensive drug syrosingopine, when combined with metformin, has a synergistic effect on various cancers. However, there is a need to develop in vivo biomarkers that can detect early clinical response.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Neurosciences

TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease

Elisa Conti, Denise Grana, Federica Angiulli, Aristotelis Karantzoulis, Chiara Villa, Romina Combi, Ildebrando Appollonio, Carlo Ferrarese, Lucio Tremolizzo

Summary: Neuroinflammation is a key mechanism in Alzheimer's disease, and this study found that oligomeric Aβ(1-42) can directly induce chemotaxis of peripheral monocytes. Interestingly, monocytes from Alzheimer's patients showed a stronger response compared to controls. TSPO was identified as a potential regulator of this process. These findings are important for future therapeutic interventions targeting monocyte motility in the central nervous system.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Gastroenterology & Hepatology

FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH

Laura G. Di Pasqua, Marta Cagna, Giuseppina Palladini, Anna C. Croce, Massimiliano Cadamuro, Luca Fabris, Stefano Perlini, Luciano Adorini, Andrea Ferrigno, Mariapia Vairetti

Summary: The effects of two FXR agonists, OCA and INT-787, on hepatic levels of various proteins in a NASH model were compared. The results showed that INT-787 is superior to OCA in controlling specific cell types and clinically relevant anti-inflammatory and antifibrotic molecular mechanisms in NASH.

LIVER INTERNATIONAL (2023)

Review Oncology

Tumor microenvironment and immunology of cholangiocarcinoma

Massimiliano Cadamuro, Luca Fabris, Xuchen Zhang, Mario Strazzabosco

Summary: Cholangiocarcinoma is an aggressive tumor with a complex tumor microenvironment, making it highly resistant to traditional chemotherapeutic drugs. The tumor microenvironment plays a crucial role in immune escape and potential therapeutic interventions.

HEPATOMA RESEARCH (2022)

Review Obstetrics & Gynecology

Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second-trimester twin stillbirth in asymptomatic woman. Case report and review of the literature

Luisa Patane, Massimiliano Cadamuro, Gabriella Massazza, Serena Pirola, Valentina Stagnati, Chiara Comerio, Marco Carnelli, Marco Arosio, Anna Paola Callegaro, Paola Tebaldi, Elena Rigoli, Andrea Gianatti, Denise Morotti

Summary: This study described a case of second-trimester twin stillbirth in a pregnant woman with SARS-CoV-2 infection. Despite the absence of respiratory symptoms, placental and fetal markers of infection indicated the possibility of vertical transmission. Fetal autopsy also showed the development of pneumonia. These findings suggest that asymptomatic pregnant women can transmit the virus vertically and lead to severe illness.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2022)

Review Gastroenterology & Hepatology

New developments and standard of care in the management of advanced gastric cancer

Leonard Depotte, Juliette Palle, Cosimo Rasola, Chloe Broudin, Vlad-Adrian Afrasanie, Antoine Mariani, Aziz Zaanan

Summary: Advanced gastric adenocarcinoma is a disease with poor prognosis. In recent years, new drugs, such as trastuzumab for HER2-positive tumors, ramucirumab alone or in combination with paclitaxel, and trifluridine-tipiracil, have improved patient survival. Other drugs, including monoclonal antibodies and targeted therapies, are also being evaluated.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2024)